SEC Insider Transactions from Mehalick David.

Last updated: 2026-03-14 11:49 UTC | Total transactions: 9

Mehalick David has filed 9 insider transactions across 1 company since January 2023.

Most recent transaction: a option exercise of 148875 shares of Coeptis Therapeutics Holdings, Inc. ($COEP) on February 11, 2026.

Activity breakdown: 3 open-market purchases and 0 sales.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
Feb. 11, 2026 Coeptis Therapeutics Holdings, Inc. $COEP Mehalick David CEO and President M Common stock 148875 $7.05 330,192.0000 4,745,089 82.11% 3.14%
Feb. 11, 2026 Coeptis Therapeutics Holdings, Inc. $COEP Mehalick David CEO and President A Common Stock 51250 $0.00 330,192.0000 4,745,089 18.37% 1.08%
March 4, 2025 Coeptis Therapeutics Holdings, Inc. $COEP Mehalick David CEO and President A Non-Qualified Stock Options (right to buy) 28875 $0.00 200,125.0000 1,924,639 16.86% 1.50%
Jan. 8, 2024 Coeptis Therapeutics Holdings, Inc. $COEP Mehalick David CEO and President P Common Stock 14004 $0.66 2,782,615.0000 1,284,499 0.51% 1.09%
Jan. 8, 2024 Coeptis Therapeutics Holdings, Inc. $COEP Mehalick David CEO and President P Common Stock 6000 $0.67 2,768,611.0000 1,284,499 0.22% 0.47%
Jan. 5, 2024 Coeptis Therapeutics Holdings, Inc. $COEP Mehalick David CEO and President P Common Stock 5050 $0.69 2,762,611.0000 1,284,499 0.18% 0.39%
Dec. 7, 2023 Coeptis Therapeutics Holdings, Inc. $COEP Mehalick David CEO and President G Common Stock 700000 $0.00 2,757,561.0000 0 20.25% 0.00%
Jan. 27, 2023 Coeptis Therapeutics Holdings, Inc. $COEP Mehalick David CEO and President A Non-qualified Stock Options (right to buy) 375000 $0.00 375,000.0000 0 9999.99% 0.00%
Jan. 27, 2023 Coeptis Therapeutics Holdings, Inc. $COEP Mehalick David CEO and President A Incentive Stock Options (right to buy) 250000 $0.00 250,000.0000 0 9999.99% 0.00%